Telesis Bio, Inc. (OTCMKTS:TBIO) Shares Shorted: Short Interest Up 117.3% in October

Telesis Bio, Inc. (OTCMKTS:TBIO – Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 176 shares, an increase of 117.3% from the October 15th total of 81 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 37 shares, the days-to-cover ratio is presently 4.8 days.

Telesis Bio Price Performance

OTCMKTS:TBIO remained flat at $0.01 on Monday. 1 shares of the company’s stock were exchanged, compared to its average volume of 150. The firm has a market capitalization of $18,000.00, a P/E ratio of -0.00 and a beta of -14.02. Telesis Bio has a 1-year low of $0.00 and a 1-year high of $0.15. The stock’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.03.

Telesis Bio Company Profile

(Get Free Report)

Telesis Bio, Inc. develops automated synthetic biology systems designed to help researchers create and test biological molecules more efficiently. Its technology is intended to streamline the design-build-test process by automating tasks that traditionally require multiple manual laboratory steps. The company’s primary products include the BioXp automated benchtop platforms and related consumables, software, and application-specific kits. These systems support the on-demand synthesis and assembly of DNA, messenger RNA and other biological constructs for applications such as gene and cell therapy research, vaccine development, protein engineering, diagnostics and synthetic biology.

Featured Articles

Receive News & Ratings for Telesis Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telesis Bio and related companies with MarketBeat.com's FREE daily email newsletter.